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   Abstract	  




Endogenous	   antioxidant	   defence	   systems	   are	   largely	   comprised	   of	   thiol	   antioxidants	   and	  
antioxidant	   enzymes.	   	   Keratin	   protein,	   being	   high	   in	   cysteic	   acid,	   has	   potential	   to	   improve	  
antioxidant	  status	  via	  generation	  of	  several	   thiol	  antioxidants.	   	  Common	  dietary	  antioxidants	  
are	   often	   used	   by	   athletes	   aiming	   to	   reduce	   oxidative	   stress,	   which	   in	   turn	   can	   improve	  
exercise	   performance.	   	  However,	  whilst	   studies	   into	   their	   action	   against	   oxidative	   stress	   are	  
positive,	  the	  subsequent	  effect	  on	  exercise	  performance	  is	  less	  so.	  	  In	  addition	  to	  having	  little	  
effect	   on	   acute	   performance,	   their	   non-­‐specific	   ROS-­‐targeting	   mechanisms	   may	   also	   blunt	  
important	  adaptation	  signalling	  pathways.	   	   It	  has	  been	  proposed	  that	   improving	  endogenous	  
defence	   systems	  may	  be	  of	   greater	  benefit	   to	   athletic	   performance,	   thus	   keratin	  may	  be	  an	  
alternative	   to	   dietary	   antioxidant	   supplementation.	   	   The	   first	   study	  within	   this	   thesis	   found	  
acute	   keratin	   supplementation	   to	   improve	   plasma	   total	   thiol	   content,	   while	   longer	   term	  
supplementation	  increased	  lean	  body	  mass	  significantly	  more	  than	  casein	  protein.	  	  Study	  two	  
suggested	  one	  week	  of	   keratin	   vs.	   taurine	   supplementation	  did	  not	   affect	   plasma	   total	   thiol	  
content,	   while	   study	   three	   found	   that	   despite	   no	   significant	   effects	   on	   serum	   total	   thiol	  
content,	   taurine	   improved	   muscle	   recovery	   following	   eccentric-­‐induced	   muscle	   damage	  
compared	  to	  a	  placebo.	  In	  summary,	  findings	  from	  this	  thesis	  suggest	  keratin	  may	  be	  a	  useful	  
supplement	   for	   athletes	   wanting	   to	   maintain	   or	   gain	   lean	   body	   mass.	   	   This	   suggests	  
implications	   for	   the	   use	   of	   keratin	   beyond	   athletes,	   potentially	   benefiting	   other	   population	  
groups	  including	  the	  elderly	  and	  the	  sick.	  	  Results	  also	  suggest	  that	  supplementing	  with	  taurine	  
following	  resistance	  exercise	  involving	  eccentric	  actions	  may	  improve	  recovery	  and	  subsequent	  
performance.	  	  This	  research	  sets	  a	  platform	  for	  further	  investigation	  into	  the	  use	  of	  keratin	  and	  
thiols	  for	  various	  areas	  of	  sporting	  performance.	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